Mega Benfocue Tablet

Adult dose

Children aged 8 years and older and adults take 1 tablet once a day.

Child dose

Children aged 8 years and older take 1 tablet once a day.

This medication should not be taken by patients with hypercalcemia, sarcoidosis (a systemic inflammatory disease of unknown cause), or renal disease. Additionally, individuals with allergic reactions to any of the components of this medicine, infants under 12 months, kidney stone patients, and those with hypersensitivity to soybean oil, soy, or peanuts should avoid taking it. It is advisable not to take this medicine concurrently with phosphates, calcium salts, oral tetracycline antibiotics, antacids, and drugs like levodopa during treatment. Infants under 1 year, patients currently receiving treatment from a doctor, children exposed to significant sunlight, individuals with hyperoxaluria, women who are pregnant or breastfeeding, and those with gastrointestinal diseases such as peptic ulcers or chronic enteritis should consult healthcare professionals before taking this medication. Consultation with professionals is also necessary for those with heart or kidney problems or metabolic disorders such as hypoproteinemia, gout, hyperlipoproteinemia, or diabetic hyperlipidemia. If symptoms such as nausea, vomiting, diarrhea, skin rash, hair loss, abdominal pain occur during usage, please discontinue the medication and consult a doctor or pharmacist immediately. This medicine may affect the menstrual cycle, and women taking specific contraceptives or at risk for thrombosis should be cautious of increased thrombotic risk. Long-term high-dose usage may lead to side effects such as nerve damage, hematological abnormalities, aggravation of peptic ulcers, or liver damage, so caution is required. This medication must be taken according to the prescribed dosages and methods, and children should take it under parental supervision. Some urinalysis results may be affected during usage, and it is advisable to avoid teas that contain tannins, such as green tea or black tea, before and after taking this medicine. Patients expected to have a lipid overload should check plasma lipid levels and adjust dosages, and if using other lipid agents, they should consider the total lipid amount for dosage adjustments. This medicine must be kept out of reach of children, stored away from direct sunlight in a cool, dry, and sealed place. It is important to avoid transferring this medication to other containers to maintain its quality.

Serious side effects

• Skin rash
• dermatitis
• edema
• hypotension
• bleeding
• pulmonary edema

Mild side effects

Nausea, vomiting, diarrhea, abdominal discomfort, constipation, rash, erythema (redness due to congestion), loose stools, dermatitis, unpleasant smell during sweating or breathing, hair loss, restlessness, gastrointestinal disorders, digestive disturbances, epigastric pain, hypotension, menstruation occurring earlier or in greater volume than usual, prolonged bleeding, sensory neuropathy or neurological symptoms, hematological adverse reactions, hyperuricemia, liver damage, hypernatremia, congestive heart failure, edema, hyperkalemia

Drug interactions

Do not take together with phosphates, calcium salts, oral tetracycline preparations, antacids, or levodopa. Consult your doctor or pharmacist when taking together with oral contraceptives that contain estrogen, anti-aldosterone agents, or triamterene.

Food interactions

Avoid teas containing tannins, such as green tea and black tea, during and before/after taking this medicine.

This medicine may be sensitive to air or moisture, so it must be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. This helps retain the efficacy and safety of the medicine for a longer period.

Appearance

Brown oval film-coated tablet

Package unit

Bottle - 60 tablets/bottle, Box - 120 tablets[(60 tablets/bottle * 2)]